Sep 2026· Proceedings of the National Academy of Sciences of the United States of America· Vol 123· 0 citations· 59 references
Medicine
TL;DR
It is shown that phage-assisted evolution can be used to rapidly optimize enzymes for the synthesis of noncanonical tyrosine derivatives in Escherichia coli and this platform provides a powerful approach for the rapid engineering of ncAA synthases amenable to use in cells.
Abstract
Significance Genetic code expansion enables the incorporation of diverse chemical functionalities into proteins, yet its utility is often limited by the availability of noncanonical amino acids (ncAAs). While in-cell ncAA biosynthesis can address this challenge, existing enzymes often lack the activity required for efficient cellular ncAA production and can be limited in substrate scope. We show that phage-assisted evolution can be used to rapidly optimize enzymes for the synthesis of noncanonical tyrosine derivatives in Escherichia coli. Our evolved variants exhibited significantly improved activities on known substrates and expanded activity to new substrates, enabling the synthesis of ncAAs previously inaccessible by the parent enzymes. This platform provides a powerful approach for the rapid engineering of ncAA synthases amenable to use in cells.
Recent advances in fully autonomous ncAA biosynthesis for GCE technology across microbial, zebrafish, and mammalian systems are summarized and emerging applications of these biosynthetic strategies in biological research and therapeutic development are highlighted.
Dan Wu, Mengxi Zhang, Yu Hu et al.· Angewandte Chemie· 0 citations
The potential of BpyAla-mediated nucleic acid cleavage is discussed, with emphasis on the development of next-generation BpyAla analogues, the exploration of alternative metal cofactors, cooperative and multi-residue design strategies, and the expansion of compatible protein scaffolds and nucleic acid substrates.
Eryn Lundrigan, Matthew T. O'Neill, J. P. Pezacki· Frontiers in Chemical Biolog...· 0 citations
Polymyxins are potent nonribosomal peptide antibiotics, yet their clinical use is limited by a narrow therapeutic window and nephro-/neurotoxicity. Conventional efforts to improve these agents rely on the incorporation of nonnatural building blocks that cannot be accessed biosynthetically and therefore must be introduc...
Maximilian Müll, Pia Lanvers, Giulia Ravagnan et al.· Angewandte Chemie· 0 citations
A comprehensive protocol for applying phage-assisted continuous evolution (PACE) strategy to select CP inhibitors against aggregation-prone proteins of interest is provided.
Lin-Wei Yang, Tina Wang· Methods in molecular biology· 0 citations
Selenocysteine (Sec), the 21st amino acid, is a rare non-canonical amino acid that represents an attractive target for protein engineering due to its desirable chemical properties such as high affinity for metals, strong nucleophilicity, and reversible covalent bond formation. To bypass the natural constraints on Sec p...
Andrew R. Gilmour, Qiyao Wei, Jessica Hellinger et al.· bioRxiv· 0 citations
Vanillyl alcohol (VNA) is a high-value compound used in the pharmaceutical industry and other fields. Its microbial de novo biosynthesis is severely limited by the low catalytic efficiency of O-methyltransferase. Here, we constructed a V314I mutant of caffeate O-methyltransferase via structure-guided protein engineerin...
Jin-Yi Li, Yong Du, Jia Wang et al.· ACS Synthetic Biology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.